Stay updated with breaking news from Patrick Wen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests a possible new treatment option for people with the slow-growing but deadly brain tumor.
A study co-led by UCLA is the first clinical trial analyzing a targeted therapy specifically developed to treat brain tumors.
Servier’s drug vorasidenib helped glioma patients stave off cancer growth
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, today announced that final data from its...